Europese Unie -
Letlands -
EMA (European Medicines Agency)
hepcludex
gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - pretvīrusu līdzekļi sistēmiskai lietošanai - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.
Letland -
Letlands -
Zāļu valsts aģentūra
cyclophosphamide accord 500 mg pulveris injekciju/infūziju šķīduma pagatavošanai
accord healthcare b.v., netherlands - ciklofosfamīds - pulveris injekciju/infūziju šķīduma pagatavošanai - 500 mg
Letland -
Letlands -
Zāļu valsts aģentūra
cyclophosphamide accord 1000 mg pulveris injekciju/infūziju šķīduma pagatavošanai
accord healthcare b.v., netherlands - ciklofosfamīds - pulveris injekciju/infūziju šķīduma pagatavošanai - 1000 mg
Letland -
Letlands -
Zāļu valsts aģentūra
torasemid hexal 10 mg tabletes
hexal ag, germany - torasemīds - tablete - 10 mg
Letland -
Letlands -
Zāļu valsts aģentūra
torasemid hexal 50 mg tabletes
hexal ag, germany - torasemīds - tablete - 50 mg
Letland -
Letlands -
Zāļu valsts aģentūra
torasemid hexal 10 mg tabletes
hexal ag, germany - torasemīds - tablete - 10 mg
Letland -
Letlands -
Zāļu valsts aģentūra
torasemid hexal 100 mg tabletes
hexal ag, germany - torasemīds - tablete - 100 mg
Europese Unie -
Letlands -
EMA (European Medicines Agency)
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
Europese Unie -
Letlands -
EMA (European Medicines Agency)
teriflunomide accord
accord healthcare s.l.u. - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - immunosuppressants, selektīvi immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
Letland -
Letlands -
Zāļu valsts aģentūra
bozilos 14 mg apvalkotās tabletes
egis pharmaceuticals plc, hungary - teriflunomīds - apvalkotā tablete - 14 mg